Multidrug-resistant infections are a growing global threat, driven by diverse bacterial resistance mechanisms, complicating efforts to develop effective, long-lasting antibiotics.
Antibiotic resistance
Antibiotic-induced dysbiosis disrupts gut microbial harmony, fuel resistance gene spread, and triggers inflammation—reshaping immunity, brain health, and future disease risks.
Phage discovery can be long and drawn out, but scientists are ready to get down with this groovy new method that skips the hassle.
The virulence of environmental microbial populations might hinge on who doesn’t become the protozoans’ lunch.
How exploiting bacterial fitness costs can help us find a way to tackle resistance in bacteria and help us use the existing drugs more effectively.
A modified macrolide called mandimycin, uniquely targets fungal cell membranes, offering potent activity against multidrug-resistant fungal pathogens.
Essential oils and tetracycline make for an antibacterial double act
Effective targets against Staphylococcus aureus could be found in the very control networks the bacteria uses to attack during infection.
Bacteria modify RNA molecules to become more resistant to the effect of antibiotics. Researchers analyze and characterize these modifications.
Co-administration of bismuth-containing compounds and antibiotics increases their antimicrobial activity, including against resistant bacterial pathogens, through disruption of iron uptake.
micro-bites.org 